Investment in biotech R&D is reportedly now outpacing that of big pharma (http://www.burrillandco.com/content/news/PR-BIO-2013-4-16-13-final.pdf ) and is driving rapid developments across the biopharmaceuticals sector. The race to…
By Norman Weichbrodt and Mike Camalo, Catalent Pharma Solutions Technology transfer is a difficult and sensitive process. For a drug service supply partner, transferring an existing…